- Home
- LPA vs CADL Comparison
LPA vs CADL Comparison
Compare LPA & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPA
- CADL
- Stock Information
- Founded
- LPA 2013
- CADL 1999
- Country
- LPA United States
- CADL United States
- Employees
- LPA N/A
- CADL N/A
- Industry
- LPA
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- LPA
- CADL Health Care
- Exchange
- LPA Nasdaq
- CADL Nasdaq
- Market Cap
- LPA 211.9M
- CADL 234.8M
- IPO Year
- LPA N/A
- CADL 2021
- Fundamental
- Price
- LPA $6.16
- CADL $4.76
- Analyst Decision
- LPA
- CADL Strong Buy
- Analyst Count
- LPA 0
- CADL 4
- Target Price
- LPA N/A
- CADL $21.00
- AVG Volume (30 Days)
- LPA 22.6K
- CADL 864.6K
- Earning Date
- LPA 05-14-2025
- CADL 05-13-2025
- Dividend Yield
- LPA N/A
- CADL N/A
- EPS Growth
- LPA N/A
- CADL N/A
- EPS
- LPA N/A
- CADL N/A
- Revenue
- LPA $43,862,372.00
- CADL N/A
- Revenue This Year
- LPA N/A
- CADL N/A
- Revenue Next Year
- LPA N/A
- CADL N/A
- P/E Ratio
- LPA N/A
- CADL N/A
- Revenue Growth
- LPA 11.22
- CADL N/A
- 52 Week Low
- LPA $6.00
- CADL $3.79
- 52 Week High
- LPA $525.00
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- LPA N/A
- CADL 41.42
- Support Level
- LPA N/A
- CADL $4.80
- Resistance Level
- LPA N/A
- CADL $5.34
- Average True Range (ATR)
- LPA 0.00
- CADL 0.33
- MACD
- LPA 0.00
- CADL 0.10
- Stochastic Oscillator
- LPA 0.00
- CADL 42.09
About LPA Logistic Properties of the Americas
Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.